ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,156 | -73.3% | 630,945 | +3.3% | 0.00% | -100.0% |
| Q2 2023 | $311,376 | -19.3% | 610,545 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $385,777 | +7.6% | 612,345 | +10.9% | 0.00% | 0.0% |
| Q4 2022 | $358,363 | -64.2% | 552,229 | -5.2% | 0.00% | -50.0% |
| Q3 2022 | $1,002,000 | +39.9% | 582,740 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $716,000 | +58.4% | 577,368 | +1.7% | 0.00% | +100.0% |
| Q1 2022 | $452,000 | -0.2% | 567,777 | +36.4% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -44.6% | 416,410 | -7.3% | 0.00% | -50.0% |
| Q3 2021 | $817,000 | -9.8% | 448,984 | +30.7% | 0.00% | 0.0% |
| Q2 2021 | $906,000 | -27.2% | 343,455 | -0.7% | 0.00% | -33.3% |
| Q1 2021 | $1,245,000 | +79.4% | 345,920 | +25.6% | 0.00% | +50.0% |
| Q4 2020 | $694,000 | +48.0% | 275,474 | +48.2% | 0.00% | +100.0% |
| Q3 2020 | $469,000 | -25.9% | 185,851 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $633,000 | +72.5% | 192,993 | +32.3% | 0.00% | 0.0% |
| Q1 2020 | $367,000 | – | 145,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |